Keyphrases
P300
100%
Therapeutic Targeting
100%
Nuclear Protein in Testis
100%
NUT Midline Carcinoma
100%
HAT Domain
100%
Bromodomain-containing Protein 4 (BRD4)
71%
Bromodomain and Extra-terminal Domain
71%
RS-485
71%
Drug Screening
14%
Epigenetics
14%
Associated Genes
14%
Synergistic Effect
14%
Therapeutic Approaches
14%
Therapeutic Target
14%
Dual Inhibition
14%
Apoptosis
14%
Histone Acetylation
14%
Cell Cycle Arrest
14%
Oncogenic Function
14%
Screening Approach
14%
Structural Genomics
14%
Squamous Cell Carcinoma (SqCC)
14%
Chromosomal Rearrangements
14%
Chemical Probes
14%
HAT Inhibitors
14%
Therapy-resistant
14%
Squamous Differentiation
14%
TP63
14%
Testis-specific Gene
14%
CCAT1
14%
Highly Aggressive
14%
Fusion Oncogene
14%
Medicine and Dentistry
Carcinoma
100%
Testes
100%
Nuclear Protein
100%
NUT Midline Carcinoma
57%
Drug Screening
14%
Malignant Neoplasm
14%
Programmed Cell Death
14%
Squamous Cell Carcinoma
14%
Histone Acetylation
14%
Cell Cycle Arrest
14%
Cell Cycle Checkpoint
14%
Gene Fusion
14%
Structural Genomics
14%
Cell Line
14%
Biochemistry, Genetics and Molecular Biology
Nuclear Protein
100%
BRD4
71%
Bromodomain
71%
Epigenetics
14%
Structural Genomics
14%
Chromosomal Rearrangement
14%
Drug Screening
14%
Cell Cycle Arrest
14%
Gene Fusion
14%
Cell Cycle Checkpoint
14%
Histone Acetylation
14%
TP63
14%
Programmed Cell Death
14%
Pharmacology, Toxicology and Pharmaceutical Science
Nuclear Protein
100%
Carcinoma
100%
Drug Screening
14%
Malignant Neoplasm
14%
Histone
14%
Squamous Cell Carcinoma
14%